Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous Regimen for Breast Cancer Management in Hong Kong
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.124
https://www.valueinhealthjournal.com/article/S1098-3015(18)32481-1/fulltext
Title :
Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous Regimen for Breast Cancer Management in Hong Kong
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32481-1&doi=10.1016/j.jval.2018.07.124
First page :
Section Title :
Open access? :
No
Section Order :
128